MX2019012902A - Preparacion de derivados de acido 2-([1,2,3]triazol-2-il)-benzoico . - Google Patents
Preparacion de derivados de acido 2-([1,2,3]triazol-2-il)-benzoico .Info
- Publication number
- MX2019012902A MX2019012902A MX2019012902A MX2019012902A MX2019012902A MX 2019012902 A MX2019012902 A MX 2019012902A MX 2019012902 A MX2019012902 A MX 2019012902A MX 2019012902 A MX2019012902 A MX 2019012902A MX 2019012902 A MX2019012902 A MX 2019012902A
- Authority
- MX
- Mexico
- Prior art keywords
- triazol
- preparation
- benzoic acid
- formula
- derivatives
- Prior art date
Links
- 239000005711 Benzoic acid Substances 0.000 title 1
- UTENUPFWBIFKPW-UHFFFAOYSA-N 2-(triazol-2-yl)benzoic acid Chemical class OC(=O)C1=CC=CC=C1N1N=CC=N1 UTENUPFWBIFKPW-UHFFFAOYSA-N 0.000 abstract 1
- -1 2H- [1,2,3] triazol-2-yl Chemical group 0.000 abstract 1
- OSPUXAXQYJCOJL-UHFFFAOYSA-N CC1(C2=NC(C=CC(Cl)=C3C)=C3N2)NC=CC1 Chemical compound CC1(C2=NC(C=CC(Cl)=C3C)=C3N2)NC=CC1 OSPUXAXQYJCOJL-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 159000000001 potassium salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
- B01J23/72—Copper
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se refiere a un proceso para la preparación de derivados de ácido 2-(2H-[1,2,3]triazol-2-iI)-benzoico particulares de la fórmula (I) (ver Fórmula) a ciertas formas cristalinas de sales de potasio de dichos derivados de ácido 2-(2H-[1,2,3]triazol-2-il)-benzoico de la fórmula (lK), a ciertas formas cristalinas de dichos derivados de ácido 2-(2H-[1,2,3]triazol-2-il)-benzoico de la fórmula (I) y a su uso en la preparación de farmacéuticos tales como (S)-(2-(5-cloro-4-metil-1H-benzo[d]imidazol-2-il)-2-metilpirrolid in-1-il)-(5-metoxi-2-(2H-1,2,3-triazol-2-il)fenil)metanona.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2017060451 | 2017-05-03 | ||
| PCT/EP2018/061172 WO2018202689A1 (en) | 2017-05-03 | 2018-05-02 | Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019012902A true MX2019012902A (es) | 2019-12-16 |
| MX392154B MX392154B (es) | 2025-03-21 |
Family
ID=62116854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019012902A MX392154B (es) | 2017-05-03 | 2018-05-02 | Preparacion de derivados de acido 2-([1,2,3]triazol-2-il)-benzoico. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US11124488B2 (es) |
| EP (1) | EP3619199B1 (es) |
| JP (1) | JP7182562B2 (es) |
| KR (1) | KR102582197B1 (es) |
| CN (1) | CN110612291B (es) |
| CA (1) | CA3059394C (es) |
| CY (1) | CY1124777T1 (es) |
| DK (1) | DK3619199T3 (es) |
| ES (1) | ES2892161T3 (es) |
| HR (1) | HRP20211304T1 (es) |
| HU (1) | HUE055904T2 (es) |
| IL (1) | IL270274B (es) |
| LT (1) | LT3619199T (es) |
| MX (1) | MX392154B (es) |
| PL (1) | PL3619199T3 (es) |
| PT (1) | PT3619199T (es) |
| RS (1) | RS62357B1 (es) |
| SI (1) | SI3619199T1 (es) |
| TW (1) | TWI756418B (es) |
| WO (1) | WO2018202689A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4138822A1 (en) | 2020-04-19 | 2023-03-01 | Idorsia Pharmaceuticals Ltd | Medical use of daridorexant |
| TW202400149A (zh) | 2022-05-13 | 2024-01-01 | 瑞士商愛杜西亞製藥有限公司 | 經噻唑并芳基-甲基取代之環狀肼-n-甲醯胺衍生物 |
| CN117736193B (zh) * | 2023-12-19 | 2024-07-23 | 南京知和医药科技有限公司 | 一种氘代稠环化合物及其制备方法与用途 |
| ES3038762A1 (es) * | 2024-04-12 | 2025-10-14 | Moehs Iberica Sl | Procedimiento de síntesis de ácido 5-metoxi-2-(2H-1,2,3-triazol-2yl)benzoico, sal sódica de dicho ácido como intermedio de síntesis y uso del ácido o de su sal en la preparación de daridorexant y ciertos intermedios en la síntesis del mismo |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2659299A1 (en) | 2006-08-15 | 2008-02-21 | Actelion Pharmaceuticals Ltd | Azetidine compounds |
| CL2007002809A1 (es) | 2006-09-29 | 2008-04-18 | Actelion Pharmaceuticals Ltd | Compuestos derivados de 3-aza biciclo [3.1.0]hexano; y su uso en el tratamiento de enfermedades tales como desordenes psicoticos y de ansiedad, desordenes del sueno, uso y abuso de sustancias psicoactivas, demencia y deterioro de funciones cognitivas |
| PE20081229A1 (es) * | 2006-12-01 | 2008-08-28 | Merck & Co Inc | Antagonistas de receptor de orexina de diazepam sustituido |
| TW200833328A (en) | 2006-12-28 | 2008-08-16 | Actelion Pharmaceuticals Ltd | 2-aza-bicyclo[3.1.0]hexane derivatives |
| ES2351079T3 (es) | 2007-05-14 | 2011-01-31 | Actelion Pharmaceuticals Ltd. | Derivados de 2-ciclopropil-tiazol. |
| US8030495B2 (en) | 2007-05-23 | 2011-10-04 | Coleman Paul J | Cyclopropyl pyrrolidine orexin receptor antagonists |
| EP2491034B1 (en) | 2009-10-23 | 2013-12-18 | Janssen Pharmaceutica, N.V. | Fused heterocyclic compounds as orexin receptor modulators |
| WO2011050202A1 (en) | 2009-10-23 | 2011-04-28 | Janssen Pharmaceutica Nv | Fused heterocyclic compounds as orexin receptor modulators |
| ES2585806T3 (es) | 2009-10-23 | 2016-10-10 | Janssen Pharmaceutica N.V. | Octahidropirrolo [3,4-c] pirroles disustituidos como moduladores de receptores de orexina |
| US20130281465A1 (en) | 2010-12-17 | 2013-10-24 | Taisho Pharmaceutical Co., Ltd. | Pyrazole derivative |
| WO2012085852A1 (en) | 2010-12-22 | 2012-06-28 | Actelion Pharmaceuticals Ltd | 3,8-diaza-bicyclo[4.2.0]oct-8-yl amides |
| EP2680697B1 (en) | 2011-03-03 | 2018-01-10 | Merck Sharp & Dohme Corp. | Process for the preparation of an orexin receptor antagonist |
| WO2012145581A1 (en) * | 2011-04-20 | 2012-10-26 | Janssen Pharmaceutica Nv | Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators |
| JPWO2013005755A1 (ja) | 2011-07-05 | 2015-02-23 | 大正製薬株式会社 | メチルピペリジン誘導体 |
| WO2013050938A1 (en) * | 2011-10-04 | 2013-04-11 | Actelion Pharmaceuticals Ltd | 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives |
| DK2776430T3 (en) | 2011-11-08 | 2016-05-09 | Actelion Pharmaceuticals Ltd | 2- (1,2,3-triazol-2-yl) benzamide and 3- (1,2,3-triazol-2-yl) PICOLINAMIDDERIVATER AS orexin receptor antagonists |
| EP2847343A4 (en) | 2012-05-09 | 2016-04-06 | Merck Sharp & Dohme | METHOD FOR PRODUCING A INTERMEDIATE PRODUCT FOR AN OREXINE RECEPTOR ANTAGONIST |
| TWI570120B (zh) | 2012-06-04 | 2017-02-11 | 艾克泰聯製藥有限公司 | 苯并咪唑脯胺酸衍生物 |
| JP2014015452A (ja) | 2012-06-15 | 2014-01-30 | Taisho Pharmaceutical Co Ltd | ピラゾール誘導体を含有する医薬 |
| AU2013328301A1 (en) * | 2012-10-10 | 2015-05-28 | Actelion Pharmaceuticals Ltd | Orexin receptor antagonists which are [ortho bi (hetero-)aryl]-[2-(meta bi (hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives |
| CN105051040A (zh) | 2013-03-12 | 2015-11-11 | 埃科特莱茵药品有限公司 | 作为食欲素受体拮抗剂的氮杂环丁烷酰胺衍生物 |
| TW201444849A (zh) | 2013-03-13 | 2014-12-01 | Janssen Pharmaceutica Nv | 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途 |
| TW201444821A (zh) | 2013-03-13 | 2014-12-01 | Janssen Pharmaceutica Nv | 經取代之哌啶化合物及其作為食慾素受體調節劑之用途 |
| JP6496733B2 (ja) | 2013-12-03 | 2019-04-03 | イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd | (s)−(2−(6−クロロ−7−メチル−1h−ベンゾ[d]イミダゾール−2−イル)−2−メチルピロリジン−1−イル)(5−メトキシ−2−(2h−1,2,3−トリアゾール−2−イル)フェニル)メタノンの結晶形及びオレキシン受容体アンタゴニストとしてのその使用 |
| UA119151C2 (uk) | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА |
| KR102330133B1 (ko) | 2013-12-04 | 2021-11-23 | 이도르시아 파마슈티컬스 리미티드 | 벤즈이미다졸-프롤린 유도체의 용도 |
| UY35993A (es) * | 2014-02-12 | 2015-08-31 | Eolas Therapeutics Inc | Prolinas / piperidinas sustituidas como antagonistas del receptor de orexina |
| WO2016020403A1 (en) | 2014-08-04 | 2016-02-11 | Sandoz Ag | Preparation of a benzoic acid derivative and its use for the preparation of suvorexant |
| CN104649983B (zh) * | 2014-12-23 | 2018-01-23 | 广东东阳光药业有限公司 | 一种酸的制备方法 |
| US10131653B2 (en) * | 2015-04-24 | 2018-11-20 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
-
2018
- 2018-05-02 KR KR1020197035319A patent/KR102582197B1/ko active Active
- 2018-05-02 SI SI201830396T patent/SI3619199T1/sl unknown
- 2018-05-02 DK DK18722948.9T patent/DK3619199T3/da active
- 2018-05-02 CA CA3059394A patent/CA3059394C/en active Active
- 2018-05-02 CN CN201880028762.9A patent/CN110612291B/zh active Active
- 2018-05-02 WO PCT/EP2018/061172 patent/WO2018202689A1/en not_active Ceased
- 2018-05-02 TW TW107114814A patent/TWI756418B/zh active
- 2018-05-02 ES ES18722948T patent/ES2892161T3/es active Active
- 2018-05-02 PT PT18722948T patent/PT3619199T/pt unknown
- 2018-05-02 PL PL18722948T patent/PL3619199T3/pl unknown
- 2018-05-02 LT LTEPPCT/EP2018/061172T patent/LT3619199T/lt unknown
- 2018-05-02 US US16/610,413 patent/US11124488B2/en active Active
- 2018-05-02 HR HRP20211304TT patent/HRP20211304T1/hr unknown
- 2018-05-02 JP JP2019559016A patent/JP7182562B2/ja active Active
- 2018-05-02 RS RS20211164A patent/RS62357B1/sr unknown
- 2018-05-02 MX MX2019012902A patent/MX392154B/es unknown
- 2018-05-02 IL IL270274A patent/IL270274B/en unknown
- 2018-05-02 EP EP18722948.9A patent/EP3619199B1/en active Active
- 2018-05-02 HU HUE18722948A patent/HUE055904T2/hu unknown
-
2021
- 2021-10-06 CY CY20211100871T patent/CY1124777T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20210114997A1 (en) | 2021-04-22 |
| CA3059394C (en) | 2023-09-12 |
| DK3619199T3 (da) | 2021-09-27 |
| LT3619199T (lt) | 2021-09-27 |
| SI3619199T1 (sl) | 2021-11-30 |
| EP3619199B1 (en) | 2021-07-07 |
| HUE055904T2 (hu) | 2021-12-28 |
| HRP20211304T1 (hr) | 2021-11-12 |
| MX392154B (es) | 2025-03-21 |
| TW201843144A (zh) | 2018-12-16 |
| PT3619199T (pt) | 2021-10-01 |
| ES2892161T3 (es) | 2022-02-02 |
| CN110612291A (zh) | 2019-12-24 |
| CN110612291B (zh) | 2024-02-13 |
| WO2018202689A1 (en) | 2018-11-08 |
| US11124488B2 (en) | 2021-09-21 |
| KR20200003097A (ko) | 2020-01-08 |
| CY1124777T1 (el) | 2022-11-25 |
| IL270274A (es) | 2019-12-31 |
| RS62357B1 (sr) | 2021-10-29 |
| IL270274B (en) | 2022-08-01 |
| TWI756418B (zh) | 2022-03-01 |
| JP7182562B2 (ja) | 2022-12-02 |
| EP3619199A1 (en) | 2020-03-11 |
| KR102582197B1 (ko) | 2023-09-22 |
| PL3619199T3 (pl) | 2021-12-20 |
| CA3059394A1 (en) | 2018-11-08 |
| JP2020518573A (ja) | 2020-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR102014006322B8 (pt) | 4-amino-6-picolinatos(heterocílicos) e 6-amino-2-pirimidina-(heterocíclica)-4-carboxilatos, e processo para controle de vegetação indesejada | |
| MX379536B (es) | Compuestos de pirimidinio sustituido y derivados para combatir plagas de animales. | |
| BR112015000160A2 (pt) | fabricação de ácido 2-(5-bromo-4-(4-ciclopropil hidronaftalen-1-il)-4h-1,2,4-triazol-3-il-tio) acético | |
| CR20140057A (es) | Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-etoxi-etil}-1h-[1,2,4]triazol sustituidos | |
| UY32096A (es) | Derivados de 2-carboxamida - cicloamino - urea especìficos, sus sales farmacèuticamente aceptables, composiciones contenièndolos, pro-farmacos de los mismos, procesos para su produciòn y aplicaciones | |
| CU20170057A7 (es) | Derivados de feniltriazol sustituido con hidroxialquilo | |
| UY34219A (es) | Compuestos de 2-(2,4,5-anilino sustituido)pirimidina | |
| MX365744B (es) | Derivados de sulfuro de trifluoroetilo o sustituidos con n-arilamidina como acaricidas e insecticidas. | |
| UY34480A (es) | Compuestos de 2-(fenilo sustituido)-ciclopentan-1,3-diona y derivados de los mismos, composiciones y métodos para controlar malezas. | |
| BR112014030674A2 (pt) | compostos n-ariltriazol como antagonistas do lpar | |
| PE20142448A1 (es) | Compuestos de n-alquiltriazol como antagonistas de lpar | |
| CR20140038A (es) | Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-alquiniloxi-etil}-1h-[1,2,4]triazol sustituidos | |
| CR20140464A (es) | Compuestos de heterociclilo | |
| ECSP13012596A (es) | Proceso de elaboración para derivados de pirimidina | |
| BR112013016982A2 (pt) | formas polimórficas de ácido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acético e usos destes | |
| MY180903A (en) | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof | |
| BR112015033042A8 (pt) | composto de azina, processos para a preparação de composto de azina, composição agroquímica, processo para a preparação de composições agroquímicas, método para controlar vegetação e uso do composto de azina | |
| PH12018501643A1 (en) | Tlr7 agonist crystalline form a, preparation method and use thereof | |
| MX2020005079A (es) | Derivados de aminotiazol utiles como agentes antiviricos. | |
| MX371337B (es) | Compuestos para protección de células. | |
| CR20160073A (es) | Compuestos plaguicidas | |
| GT201500292A (es) | Formas cristalinas de inhibidores de tirosina cinasa y sus sales | |
| CU20180028A7 (es) | DERIVADOS DE IMIDAZO[4,5-b]PIRIDINA, ÚTILES COMO INHIBIDORES DUALES DE DYRK1/CLK1 Y COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN | |
| WO2015049645A3 (en) | An improved process for the preparation of dasatinib | |
| MX392154B (es) | Preparacion de derivados de acido 2-([1,2,3]triazol-2-il)-benzoico. |